BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27509004)

  • 21. Effect of stereo and regiochemistry towards wild and multidrug resistant HIV-1 virus: viral potency of chiral PETT derivatives.
    Venkatachalam TK; Mao C; Uckun FM
    Biochem Pharmacol; 2004 May; 67(10):1933-46. PubMed ID: 15130770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation.
    Valera MS; de Armas-Rillo L; Barroso-González J; Ziglio S; Batisse J; Dubois N; Marrero-Hernández S; Borel S; García-Expósito L; Biard-Piechaczyk M; Paillart JC; Valenzuela-Fernández A
    Retrovirology; 2015 Jun; 12():53. PubMed ID: 26105074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic Characterization of Novel HIV-1 Entry Inhibitors: Discovery of a Relationship between Off-Rate and Potency.
    Meuser ME; Murphy MB; Rashad AA; Cocklin S
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30081466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs.
    Kumar Kushwaha P; Saurabh Srivastava K; Kumari N; Kumar R; Mitra D; Sharon A
    Bioorg Med Chem; 2022 Feb; 56():116612. PubMed ID: 35026631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif.
    Walker RC; Khan MA; Kao S; Goila-Gaur R; Miyagi E; Strebel K
    J Virol; 2010 May; 84(10):5201-11. PubMed ID: 20219919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays.
    Chen W; Zhan P; Rai D; De Clercq E; Pannecouque C; Balzarini J; Zhou Z; Liu H; Liu X
    Bioorg Med Chem; 2014 Mar; 22(6):1863-72. PubMed ID: 24581546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
    Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
    J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses.
    Côté B; Burch JD; Asante-Appiah E; Bayly C; Bédard L; Blouin M; Campeau LC; Cauchon E; Chan M; Chefson A; Coulombe N; Cromlish W; Debnath S; Deschênes D; Dupont-Gaudet K; Falgueyret JP; Forget R; Gagné S; Gauvreau D; Girardin M; Guiral S; Langlois E; Li CS; Nguyen N; Papp R; Plamondon S; Roy A; Roy S; Seliniotakis R; St-Onge M; Ouellet S; Tawa P; Truchon JF; Vacca J; Wrona M; Yan Y; Ducharme Y
    Bioorg Med Chem Lett; 2014 Feb; 24(3):917-22. PubMed ID: 24412110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 subtype variability in Vif derived from molecular clones affects APOBEC3G-mediated host restriction.
    Lisovsky I; Schader SM; Sloan RD; Oliveira M; Coutsinos D; Bernard NF; Wainberg MA
    Intervirology; 2013; 56(4):258-64. PubMed ID: 23689841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
    Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
    J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
    Russell RA; Pathak VK
    J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of Triazoles and Triazolium Salts Based on AZT and Their Anti-Viral Activity against HIV-1.
    de Alencar DM; Gonçalves J; Vieira A; Cerqueira SA; Sebastião C; Leitão MIPS; Francescato G; Antenori P; Soares H; Petronilho A
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface.
    Letko M; Booiman T; Kootstra N; Simon V; Ooms M
    Cell Rep; 2015 Dec; 13(9):1789-99. PubMed ID: 26628364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity.
    Yamashita T; Nomaguchi M; Miyake A; Uchiyama T; Adachi A
    Microbes Infect; 2010 Feb; 12(2):166-71. PubMed ID: 19944180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitors.
    Zhan P; Chen X; Li X; Li D; Tian Y; Chen W; Pannecouque C; De Clercq E; Liu X
    Eur J Med Chem; 2011 Oct; 46(10):5039-45. PubMed ID: 21872971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase.
    Sweeney ZK; Acharya S; Briggs A; Dunn JP; Elworthy TR; Fretland J; Giannetti AM; Heilek G; Li Y; Kaiser AC; Martin M; Saito YD; Smith M; Suh JM; Swallow S; Wu J; Hang JQ; Zhou AS; Klumpp K
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4348-51. PubMed ID: 18625554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors.
    Kim J; Kwon J; Lee D; Jo S; Park DS; Choi J; Park E; Hwang JY; Ko Y; Choi I; Ju MK; Ahn J; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Ahn S; Sommer P; Liuzzi M; No Z; Lee J
    Bioorg Med Chem Lett; 2013 Jan; 23(1):153-7. PubMed ID: 23206860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetrazole and triazole as bioisosteres of carboxylic acid: discovery of diketo tetrazoles and diketo triazoles as anti-HCV agents.
    Song WH; Liu MM; Zhong DW; Zhu YL; Bosscher M; Zhou L; Ye DY; Yuan ZH
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4528-31. PubMed ID: 23856047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.
    Kikuchi T; Iwabu Y; Tada T; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T
    J Virol; 2015 May; 89(9):4992-5001. PubMed ID: 25717111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baculiferins A-O, O-sulfated pyrrole alkaloids with anti-HIV-1 activity, from the Chinese marine sponge Iotrochota baculifera.
    Fan G; Li Z; Shen S; Zeng Y; Yang Y; Xu M; Bruhn T; Bruhn H; Morschhäuser J; Bringmann G; Lin W
    Bioorg Med Chem; 2010 Aug; 18(15):5466-74. PubMed ID: 20624681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.